150 related articles for article (PubMed ID: 29485445)
1. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
Yang Y; Wang W; Kan Y; Liu J; Yang J
Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
Kim SH; Zeon SK; Choi BW; Kim HW; Won KS; Kim SJ
Clin Nucl Med; 2011 Jul; 36(7):587-9. PubMed ID: 21637068
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
4. The value of
Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT Findings of Renal Cell Carcinoma Arising From a Transplanted Kidney in a Pediatric Patient.
Fleury AS; Zhuang H
Clin Nucl Med; 2023 Dec; 48(12):e605-e607. PubMed ID: 37844572
[TBL] [Abstract][Full Text] [Related]
6.
Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT Findings of the Recurrent Posttransplantation Lymphoproliferative Disorder in a Pediatric Liver Transplant Recipient With Right Leg Pain as the Only Complaint.
Bai X; Yang H; Zhuang H
Clin Nucl Med; 2015 Oct; 40(10):832-4. PubMed ID: 26098286
[TBL] [Abstract][Full Text] [Related]
8. Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18 F-FDG PET/CT.
Feng L; Yang X; Lu X; Wang W; Yang J
Clin Nucl Med; 2022 Nov; 47(11):1007-1009. PubMed ID: 35835131
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS
Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
[TBL] [Abstract][Full Text] [Related]
10. 18 F-FDG PET/CT in Renal Allograft Tuberculosis Mimicking as Posttransplant Malignancy.
Moideen A; Singh H; Kumar R; Naik SM; Gupta A; Sekar A; Nada R
Clin Nucl Med; 2024 Feb; 49(2):e52-e53. PubMed ID: 38049975
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT.
Ward J; Noy A; Ulaner G; Riedl C
Clin Nucl Med; 2018 May; 43(5):344-345. PubMed ID: 29538028
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
13. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
Clin Nucl Med; 2009 Jun; 34(6):386-7. PubMed ID: 19487854
[No Abstract] [Full Text] [Related]
14. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
15. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT Findings of a Synovial Sarcoma in a Renal Transplant.
Yang X; Wang W; Kan Y; Liu J; Yang J
Clin Nucl Med; 2019 Mar; 44(3):259-261. PubMed ID: 30589671
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT in 2 Cases of Hepatic Pseudolymphoma.
Zhong X; Dong A; Dong H; Wang Y
Clin Nucl Med; 2018 May; 43(5):e166-e169. PubMed ID: 29517544
[TBL] [Abstract][Full Text] [Related]
18. Post-heart transplantation lymphoproliferative diseases (PTLDs) and the diagnostic role of [18f] FDG-PET/CT.
Sica A; DE Rimini ML; Sagnelli C; Casale B; Spada A; Reginelli A; Amarelli C; Maiello C; Belfiore MP; Creta M; Ciccozzi M; Sagnelli E; Troiani T; Cappabianca S
Minerva Med; 2021 Jun; 112(3):338-345. PubMed ID: 32407047
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disease in a pediatric patient as seen on PET/CT scan.
Bagga S
Clin Nucl Med; 2007 Jul; 32(7):553-4. PubMed ID: 17581345
[No Abstract] [Full Text] [Related]
20.
Treglia G; Ceriani L
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):523-524. PubMed ID: 31485683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
